Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4Δ30-4995 in Healthy Adult Volunteers

rDEN4Δ30-4995 is a live attenuated dengue virus type 4 (DENV4) vaccine candidate specifically designed as a further attenuated derivative of the rDEN4Δ30 parent virus. In a previous study, 5 of 20 vaccinees who received 10(5) plaque-forming units (PFU) of rDEN4Δ30 developed a transient elevation of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Wright, Peter F., Durbin, Anna P., Whitehead, Stephen S., Ikizler, Mine R., Henderson, Susan, Blaney, Joseph E., Thumar, Bhavin, Ankrah, Sharon, Rock, Michael T., McKinney, Brett A., Murphy, Brian R., Schmidt, Alexander C.
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2829759/
https://ncbi.nlm.nih.gov/pubmed/19861619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.2009.09-0131
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares